Analysis: Large pharma companies do little new drug innovation - STAT

Analysis: Large pharma companies do little new drug innovation - STAT

Opinion: Do large pharma companies provide drug development innovation? Our analysis says no

By EMILY H. JUNG AND ALFRED ENGELBERG AND AARON S. KESSELHEIM

ADOBE

Among their top-selling drugs, 76% of Pfizer's and 89% of J&J's were developed by other companies and account for nearly 90% of revenues.

READ MORE